Back to Search
BRANT CUMMINGS, PHARMD
PHARMD
Pharmacist
NPI: 1497595706Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
62741(TX)
Research & Publications (20)
Interfraction and respiratory organ motion during conformal radiotherapy in gastric cancer.
PMID 19665320·Int J Radiat Oncol Biol Phys·2010
8-other
Measurements of airborne methylene diphenyl diisocyanate (MDI) concentration in the U.S. workplace.
PMID 19191163·J Occup Environ Hyg·2009
8-other
Multiple channel bridges for spinal cord injury: cellular characterization of host response.
PMID 19382871·Tissue Eng Part A·2009
7-preclinical
Truths and myths about radiotherapy for verrucous carcinoma of larynx.
PMID 18707828·Int J Radiat Oncol Biol Phys·2009
8-other
Phase I study of individualized stereotactic body radiotherapy of liver metastases.
PMID 19255313·J Clin Oncol·2009
3-trial
Characterization of human lysophospholipid acyltransferase 3.
PMID 19351971·J Lipid Res·2009
7-preclinical
Long-term, stable differentiation of human embryonic stem cell-derived neural precursors grafted into the adult mammalian neostriatum.
PMID 19609935·Stem Cells·2009
7-preclinical
Analysis of host-mediated repair mechanisms after human CNS-stem cell transplantation for spinal cord injury: correlation of engraftment with recovery.
PMID 19517014·PLoS One·2009
7-preclinical
Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses.
PMID 19208729·J Clin Endocrinol Metab·2009
2-rct
Plasmid releasing multiple channel bridges for transgene expression after spinal cord injury.
PMID 19050701·Mol Ther·2009
7-preclinical
Inhibition of Ca2+-independent phospholipase A2 decreases prostate cancer cell growth by p53-dependent and independent mechanisms.
PMID 18441250·J Pharmacol Exp Ther·2008
4-observational
Alterations in phospholipid and fatty acid lipid profiles in primary neocortical cells during oxidant-induced cell injury.
PMID 18602625·Chem Biol Interact·2008
7-preclinical
A phase I/II study to evaluate the toxicity and efficacy of accelerated fractionation radiotherapy for the palliation of dysphagia from carcinoma of the oesophagus.
PMID 18345545·Clin Oncol (R Coll Radiol)·2008
3-trial
Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: quality of life in a prospective phase I/II trial.
PMID 18215435·Radiother Oncol·2008
3-trial
Metabolic and endocrine profiles in response to systemic infusion of fructose and glucose in rhesus macaques.
PMID 18308841·Endocrinology·2008
7-preclinical
Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat.
PMID 18832086·Am J Physiol Regul Integr Comp Physiol·2008
7-preclinical
Decreased iPLA2gamma expression induces lipid peroxidation and cell death and sensitizes cells to oxidant-induced apoptosis.
PMID 18398221·J Lipid Res·2008
7-preclinical
Lack of influence of intravenous contrast on head and neck IMRT dose distributions.
PMID 17934894·Acta Oncol·2008
8-other
Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
PMID 18172187·J Clin Oncol·2008
3-trial
Identification, coassembly, and activity of gamma-aminobutyric acid receptor subunits in renal proximal tubular cells.
PMID 17959749·J Pharmacol Exp Ther·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 602 INDIANA AVE
LUBBOCK, TX 79415 - Phone
- (806) 775-9175
Quick Facts
- NPI
- 1497595706
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile